Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view.
CONCLUSION: In our experience, sacubitril/valsartan is safe in CKD, offering stability in CKD progression after 6 months.
PMID: 31027894 [PubMed - as supplied by publisher]
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - Category: Urology & Nephrology Tags: Nefrologia Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Diovan | Epidemiology | Heart | Study | Urology & Nephrology